Last data update: May 12, 2025. (Total: 49248 publications since 2009)
Records 1-3 (of 3 Records) |
Query Trace: Gabriel MG[original query] |
---|
Association of infection-induced antibody levels with risk of subsequent SARS-COV-2 reinfection among healthcare professionals, Rhode Island, 1 March 2020-17 February 2021
Shi J , Gabriel MG , Epperson M , Chan PA , Jones JM , Petersen LR , Briggs Hagen M , Thornburg NJ , Saydah S , Midgley CM . Microbiol Spectr 2025 e0208624 Numerous studies have investigated vaccine-induced correlates of protection (CoP) against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection, but data on infection-induced CoP are limited. Given differences between vaccine- and infection-induced immune responses, in conjunction with low vaccination in many US populations, a better understanding of infection-induced CoP is needed. We used residual sera from a mid-2020 Rhode Island serosurvey of healthcare professionals (HCP) and corresponding state-collected SARS-CoV-2 testing data through February 2021 to generate an analytic cohort of HCP with a first SARS-CoV-2 infection prior to serosurvey blood collection and multiple viral tests after blood collection to assess for reinfection (defined as a positive viral test ≥90 days after their first positive). We tested sera for levels of IgG and IgA targeting ancestral spike (S), receptor-binding domain (RBD), or nucleocapsid (N). We used adjusted Cox proportional hazard ratios to assess the association between categorical antibody level and the risk of subsequent reinfection. Among 170 HCP included in this analysis (median age = 47 years; interquartile range: 35-55 years), 30 were reinfected during the analytic period. Adjusted Cox proportional hazard ratios indicated that higher levels of anti-S or anti-RBD IgG were significantly associated with a lower risk of reinfection. These findings support the use of anti-S or anti-RBD IgG levels as markers of immunologic protection, such as in population serosurveys, or immune-bridging studies in settings of high prevalence of prior infection. IMPORTANCEThe measurement of antibodies in blood is a relatively simple process and commonly used to estimate overall levels of past infection in populations. But, if someone has antibodies, does this mean that they are protected from being infected again? And are people with higher levels of antibody better protected? There are good data in the literature exploring how antibodies from the coronavirus disease 2019 (COVID-19) vaccination are associated with protection. But, there is still a lot to learn about protection conferred by antibodies that develop after a severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection. In our study, we measure the levels of six different antibody types developed after infection and compare levels to the risk of subsequent infection to better understand which antibody types are best associated with protection. Our data are important for improving studies that use antibodies as proxies for protection, such as population immunity estimates, or those assessing new prevention products. |
Changes in racial and ethnic disparities of HIV diagnoses among adolescents and young adults aged 13-24years, 2015-2019
Gabriel MG , Eppink ST , Henny KD , Chesson H , McCree DH . J Adolesc Health 2022 72 (1) 59-63 PURPOSE: We examined changes in racial/ethnic disparities in HIV diagnoses among adolescents and young adults aged 13-24years from 2015 through2019. METHODS: We used national surveillance data for 2015-2019 from AtlasPlus to calculate 12 absolute and relative disparity measures for 7 racial/ethnic groups to understand HIV diagnosis trends over time. We calculated four absolute measures (Black-to-White rate difference, Hispanic-to-White rate difference, Absolute Index of Disparity [ID], population-weighted Absolute ID) and eight relative measures (Black-to-White rate ratio, Hispanic-to-White rate ratio, ID, population-weighted ID, population attributable proportion, Gini coefficient, Theil index, and mean log deviation). RESULTS: HIV diagnosis rates decreased by 15.9% across all racial/ethnic groups combined. All the absolute disparity measures we examined indicated substantial reductions (13.5%-18.5%) in absolute disparities. Most of the relative disparity measures (eight of eight population-unadjusted measures and five of eight population-adjusted measures) declined as well, but the change was relatively modest and ranged from a 3.3% decrease to a 2.1% increase across the measures. DISCUSSION: Despite progress, racial/ethnic disparities in HIV diagnoses among adolescents and young adults remain. Programs and services that are culturally relevant and tailored for this population may assist with continued progress toward reducing racial/ethnic disparities. |
Power and social control of youth during the COVID-19 pandemic
Gabriel MG , Brown A , León M , Outley C . Leis Sci 2020 43 240-246 While people across the globe adapt to the COVID-19 pandemic, young people have been the center of many news stories. Millions of young people are required to stay home due to school closures, and adults are forced to consider alternative structures to support youths’ needs. The COVID-19 pandemic has exposed multiple injustices and forms of oppression experienced by the most vulnerable in our country, which includes young people experiencing poverty, incarceration, foster care, homelessness, and those with marginalized identities. This article will discuss the role of power and social control in the lives of youth during the COVID-19 pandemic and present strategies leisure researchers and practitioners can adopt to overcome the loss of critical support structures and mitigate exponential effects of COVID-19 on our most vulnerable youth. |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 12, 2025
- Content source:
- Powered by CDC PHGKB Infrastructure